Early exercise in blunt chest wall trauma: protocol for a mixed-methods, multicentre, parallel randomised controlled trial (ELECT2 trial). Issue 4 (7th April 2022)

• Record Type: Journal Article
• Authors: Battle, Ceri; Charnock, Amy; Davies, Sara; Davies, Susan; Dawson, Thomas; Driscoll, Timothy; Evans, Phillip A; Fitzsimmons, Deborah; Harris, Shaun; Jones, Kate; Lecky, Fiona Elizabeth; O'Neill, Claire; Prosser, Joanne; Toghill, Hannah; Watkins, Alan; Hutchings, Hayley Anne
• Is Part Of: BMJ open. Volume 12:Issue 4(2022)
• Publication Date: 2022-04-07
• Subjects: TRAUMA MANAGEMENT -- REHABILITATION MEDICINE -- PAIN MANAGEMENT; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2021-060055
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: Chronic pain and disability are now well-recognised long-term complications of blunt chest wall trauma. Limited research exists regarding therapeutic interventions that can be used to address these complications. A recent feasibility study was completed testing the methods of a definitive trial. This protocol describes the proposed definitive trial, the aim of which is to investigate the impact of an early exercise programme on chronic pain and disability in patients with blunt chest wall trauma. Methods/analysis: This mixed-methods, multicentre, parallel randomised controlled trial will run in four hospitals in Wales and one in England over 12-month recruitment period. Patients will be randomised to either the control group (routine physiotherapy input) or the intervention group (routine physiotherapy input plus a simple exercise programme completed individually by the patient). Baseline measurements including completion of two surveys (Brief Pain Inventory and EuroQol 5-dimensions, 5-Levels) will be obtained on initial assessment. These measures and a client services receipt inventory will be repeated at 3-month postinjury. Analysis of outcomes will focus on rate and severity of chronic pain and disability, cost-effectiveness and acceptability of the programme by patients and clinicians. Qualitative feedback regarding acceptability will be obtained through patient and clinician focus groups. Ethics/dissemination: London Riverside Research Ethics Committee (Reference number: 21/LO/0782) and the Health Research Authority granted approval for the trial in December 2021. Patient recruitment will commence in February 2022. Planned dissemination is through publication in a peer-reviewed Emergency Medicine Journal, presentation at appropriate conferences and to stakeholders at professional meetings. Trial registration number: ISRCTN65829737; Pre-results .